Connect
MJA

The increasing use of shave biopsy for diagnosing invasive melanoma in Australia

Sara L Menezes, John W Kelly and Victoria Mar
Med J Aust 2020; 212 (5): . || doi: 10.5694/mja2.50502
Published online: 16 March 2020

In reply: We thank Byth and Byth for sharing their perspectives on our article.1 The authors queried whether better equipment and training over the 10‐year period may have had an impact on base transection rates. In fact, our data suggest poorer performance over time, with base transection rates for shave biopsies of 45% (17/37), 55% (32/58) and 56% (45/80) in 2005, 2010 and 2015 respectively (unpublished data).

  • Sara L Menezes1,2
  • John W Kelly1,2
  • Victoria Mar1,2

  • 1 Victorian Melanoma Service, Alfred Health, Melbourne, VIC
  • 2 Monash University Central Clinical School, Melbourne, VIC

Correspondence: 

Competing interests:

Victoria Mar and John Kelly are involved in developing the Cancer Council melanoma clinical practice guidelines.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.